CardioDx

CardioDx Inc was incorporated in Delaware in July 2003. The Company is a molecular diagnostics company developing and commercializing novel, proprietary tests that help improve treatment decisions, enhance patient outcomes and reduce the overall cost of care. It uses genomic technologies to provide healthcare professionals with critical, actionable information to improve patient care and management. It focuses on diagnostics for cardiovascular diseases, such as coronary artery diseases, or CAD, arrhythmia and heart failure. Its Corus CAD test is a blood-based gene expression test that provides a current-state assessment for non-diabetic patients with symptoms that are suggestive of obstructive CAD.

Kleiner Perkins

🏥 Healthcare